DelMar Pharmaceuticals to Present at the 18th Annual Rodman & Renshaw Global Investment Conference on September 13, 2016 August 30, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals to Present at the 11th Biennial Ovarian Cancer Research Symposium August 11, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016 July 21, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals to Ring the Nasdaq Stock Market Opening Bell on July 14 July 13, 2016 • 8:30 AM EDT
DelMar Pharmaceuticals Presents Phase I/II GBM Clinical Trial Data and Outlines Future Clinical Development Plans at ASCO 2016 Annual Meeting June 6, 2016 • 8:00 AM EDT
DelMar Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting with FDA on VAL-083 for the Treatment of Refractory Glioblastoma Multiforme May 25, 2016 • 8:00 AM EDT
DelMar Pharmaceuticals Announces Reverse Stock Split in Preparation for Proposed Senior Exchange Uplisting May 19, 2016 • 10:16 AM EDT
DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2016 Financial Results and Corporate Update May 13, 2016 • 8:00 AM EDT
DelMar Pharmaceuticals, Inc. Announces $5.6 Million Private Placement Of Preferred Shares May 5, 2016 • 8:00 AM EDT